美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
43598-674-50	43598-674	HUMAN PRESCRIPTION DRUG	Cefixime	Cefixime	POWDER, FOR SUSPENSION	ORAL	20170803	N/A	ANDA	ANDA206938	Dr. Reddy’s Laboratories, Inc	CEFIXIME	200 mg/5mL	50 mL in 1 BOTTLE (43598-674-50)
43598-674-51	43598-674	HUMAN PRESCRIPTION DRUG	Cefixime	Cefixime	POWDER, FOR SUSPENSION	ORAL	20170803	N/A	ANDA	ANDA206938	Dr. Reddy’s Laboratories, Inc	CEFIXIME	200 mg/5mL	75 mL in 1 BOTTLE (43598-674-51)
43598-673-50	43598-673	HUMAN PRESCRIPTION DRUG	Cefixime	Cefixime	POWDER, FOR SUSPENSION	ORAL	20170803	N/A	ANDA	ANDA206938	Dr. Reddy’s Laboratories, Inc	CEFIXIME	100 mg/5mL	50 mL in 1 BOTTLE (43598-673-50)
62250-664-26	62250-664	HUMAN PRESCRIPTION DRUG	Cefixime	cefixime	POWDER, FOR SUSPENSION	ORAL	20170315	N/A	ANDA	ANDA206938	Belcher Pharmaceuticals,LLC	CEFIXIME	200 mg/5mL	50 mL in 1 BOTTLE (62250-664-26)
62250-664-27	62250-664	HUMAN PRESCRIPTION DRUG	Cefixime	cefixime	POWDER, FOR SUSPENSION	ORAL	20170315	N/A	ANDA	ANDA206938	Belcher Pharmaceuticals,LLC	CEFIXIME	200 mg/5mL	75 mL in 1 BOTTLE (62250-664-27)
62250-664-28	62250-664	HUMAN PRESCRIPTION DRUG	Cefixime	cefixime	POWDER, FOR SUSPENSION	ORAL	20170315	N/A	ANDA	ANDA206938	Belcher Pharmaceuticals,LLC	CEFIXIME	200 mg/5mL	100 mL in 1 BOTTLE (62250-664-28)
62250-663-26	62250-663	HUMAN PRESCRIPTION DRUG	Cefixime	cefixime	POWDER, FOR SUSPENSION	ORAL	20170315	N/A	ANDA	ANDA206938	Belcher Pharmaceuticals,LLC	CEFIXIME	100 mg/5mL	50 mL in 1 BOTTLE (62250-663-26)
62250-663-27	62250-663	HUMAN PRESCRIPTION DRUG	Cefixime	cefixime	POWDER, FOR SUSPENSION	ORAL	20170315	N/A	ANDA	ANDA206938	Belcher Pharmaceuticals,LLC	CEFIXIME	100 mg/5mL	75 mL in 1 BOTTLE (62250-663-27)
62250-663-28	62250-663	HUMAN PRESCRIPTION DRUG	Cefixime	cefixime	POWDER, FOR SUSPENSION	ORAL	20170315	N/A	ANDA	ANDA206938	Belcher Pharmaceuticals,LLC	CEFIXIME	100 mg/5mL	100 mL in 1 BOTTLE (62250-663-28)